Isoniazid - Bridge BioResearch

Drug Profile

Isoniazid - Bridge BioResearch

Alternative Names: BBR-012; Isoniazide - Bridge BioResearch

Latest Information Update: 14 Aug 2015

Price : $50

At a glance

  • Originator Bridge BioResearch
  • Class Antibacterials; Antituberculars; Carboxylic acids; Hydrazines; Isonicotinic acids; Small molecules
  • Mechanism of Action Cell wall inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Diabetic foot ulcer

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 05 Jul 2011 Phase-II clinical trials in Diabetic foot ulcer in United Kingdom (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top